Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_assertion type Assertion NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_head.
- NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_assertion description "[Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_provenance.
- NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_assertion evidence source_evidence_literature NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_provenance.
- NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_assertion SIO_000772 23768755 NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_provenance.
- NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_assertion wasDerivedFrom befree-2016 NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_provenance.
- NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_assertion wasGeneratedBy ECO_0000203 NP1086076.RAkGw1Mlzhw6rByBd1jyGO4NWk8QAXz9imDe18Wvpid08130_provenance.